Details of HIV-1 structure open door for potential therapies

August 9, 2018 by Krishna Ramanujan, Cornell University
HIV-1 protein structure stained and viewed under an electron microscope. Credit: Robert Dick

New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

The study, authored by a multi-institutional team led by Cornell researchers, was published Aug. 1 in the journal Nature.

The study reports that a small molecule called IP6, found in mammalian , plays key roles in the immature development of the (which occurs within an infected cell) and in the mature development of the virus (which occurs after the virus buds out of the cell membrane and cleaves from the cell).

"This small molecule acts in two different assembly steps in the pathway," said Robert Dick, a postdoctoral researcher and the paper's first author. Dick works in the lab of Volker Vogt, professor in the Department of Molecular Biology and Genetics and the paper's senior author.

In both the immature and mature phases of the virus' development, IP6 plays key roles in the pathways to create structural lattices. It facilitates assembly of an immature while the virus develops inside the cell. This lattice breaks down after the virus buds and is cleaved from the cell membrane. At that point, IP6 also promotes the assembly of a second, mature lattice within the virus particle.

In the study, the researchers purified a structural , called a Gag protein, mixed it with a form of nucleic acid that acted as a template, and formed a protein virus lattice of the type found in the immature phase. Using a stain and an electron microscope, Dick and colleagues looked at the round (essentially just the protein virus lattice) on a grid.

The researchers repeated assembly reactions with the Gag protein and nucleic acid and a buffer in the presence and absence of IP6, Dick said: "Those first few experiments told us we were observing something pretty dramatic. The presence of IP6 greatly increased the number of virus particles we could detect."

The naturally-occurring compound IP6 (red) facilitates the formation and assembly of HIV-1 structural proteins, results from XSEDE Stampede2 and Anton2 systems show. Credit: Juan R. Perilla, University of Delaware

Still, the researchers were unsure where IP6 was acting on the Gag protein to have an effect, so they made different versions of the Gag protein and narrowed down the site of activity to make a prediction of where the small IP6 molecule was acting to create the lattice structure.

At that point, they approached co-authors Owen Pornillos and Barbie Ganser-Pornillos, both in the Department of Molecular Physiology and Biological Physics at the University of Virginia, who generated crystallographic data of the IP6 molecule interacting with the Gag structure.

In the mature phase, the researchers found that IP6 interacts at a site that is revealed after the virus particle cuts away from the cell. At that point, an entirely new lattice develops, made of different proteins than the immature lattice.

The findings open the door to possible new therapies. One option is for researchers to develop or identify compounds that are similar to IP6 and could bind to the same sites as IP6, thereby blocking it and preventing the virus from maturing.

"A cell can make millions of virus particles, but if they don't go through the maturation process, they are not infectious," Dick said.

Co-authors included teams of researchers from the University of Delaware; the European Molecular Biology Laboratory in Heidelberg, Germany; the Institute of Science and Technology in Klosterneuburg, Austria; and the University of Missouri.

Explore further: Researchers pinpoint exactly where each building block sits in HIV

More information: Robert A. Dick et al, Inositol phosphates are assembly co-factors for HIV-1, Nature (2018). DOI: 10.1038/s41586-018-0396-4

Related Stories

Researchers pinpoint exactly where each building block sits in HIV

November 3, 2014
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany and collaborators from Heidelberg University, in the joint Molecular Medicine Partnership Unit, have obtained the first structure of the ...

Researchers make key discovery about human cancer virus protein

May 15, 2018
University of Minnesota researchers in the dentistry school-based Institute for Molecular Virology (IMV) have made a key discovery that could have important implications for developing a strategy to stop the spread of a highly ...

Recommended for you

Long-acting injectable implant shows promise for HIV treatment and prevention

October 9, 2018
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.

Scientists develop rapid test for diagnosing tuberculosis in people with HIV

October 8, 2018
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected ...

Researchers uncover new role of TIP60 protein in controlling tumour formation

October 8, 2018
Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a new molecular pathway that controls colorectal cancer development, and their exciting ...

Combination therapy targets latent reservoir of HIV

October 3, 2018
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

Anti-integrin therapy effect on intestinal immune system in HIV-infected patients

October 3, 2018
In a study published today in Science Translational Medicine, Mount Sinai researchers describe for the first time a mechanism that may shrink collections of immune cells in the gastrointestinal (GI) tract, called lymphoid ...

No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

October 1, 2018
In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.